Top Banner
COMPLICATION AND TREATMENT OF ACUTE RESPIRATORY DISTRESS
26
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Respiratory distress syndrome

COMPLICATION AND TREATMENT OF ACUTE

RESPIRATORY DISTRESS

Page 2: Respiratory distress syndrome

Treatment

• Start with Neonatal Resuscitation Program!

Page 3: Respiratory distress syndrome

Surfactant Therapy

• most effectively in infants <30 weeks and those birthweight <1250g

• Who to give surfactant to?

• depressed preterm infants who have no spontaneous respiration after 30 s of ventilation

• preterm infants below 28 weeks gestation

• preterm infants between 28-32 weeks

• more mature or larger infants

Page 4: Respiratory distress syndrome

Timing of Surfactant Therapy

• attempts to treat with surfactant before the infant can breathe resulted in more BPD

• there fore surfactant delivery within first minutes of life not indicated

• the first dose has to be given as early as possible to the preterm infants requiring mechanical ventilation.

• the repeat dose is given 4-6 hours later based on FiO2

Page 5: Respiratory distress syndrome

Surfactants

• Survanta, a natural surfactant, bovine derived 4ml/kg/dose

• Curosur, a natural surfactant, porcine derived 1.25ml/kg/dose

Page 6: Respiratory distress syndrome

Surfactant Therapy

• Multidose endotracheal instillation: 4ml/kg

• Treatment (rescue) is initiated as soon as possible n the 1st 24hour of life

• Dose repeated - via the ET tube 6-12 hourldy for a total 2-4 doses

Page 7: Respiratory distress syndrome

• PaO2 should be maintained between 60-70mmHg

• pH should be maintained above 7.25

• if hypoxemia (PaO2 < 50mmHg) nCPAP should be added at 8 to 10 cmH20.

Page 8: Respiratory distress syndrome

Supportive Treatment

• Avoid Hypothermia

• IV Fluids and Calories

• Warm Humidified O2

Page 9: Respiratory distress syndrome

Ventilation

• Controlled

• if infant have no breathing effort, no option to override ventilator

• a preset peak inspiratory pressure is delivered to the patient at preset respiratory rate

• Supported

• Continous Positive Airway Pressure (CPAP) - infant has breathing effort and to prevent the collapse of the alveoli

• based on peak end expiratory flow (PEEP)

Page 10: Respiratory distress syndrome

Prevention

• Prevention of prematurity

• Betamethasone to women 48 hour before delivery 12mg IM for 2 doses 12 hours apart

• cervical cerclage, bed rest treatment of infections, and administration of tocolytic medication

• prevention of neonatal cold stress, birth asphyxia and hypovolemia

Page 11: Respiratory distress syndrome

Acute Complication

• Apnoea of Prematurity

• Air Leak

• Patent Ductus Arteriosus

• Infection

• Intracranial Haemorrhage

• Prmary Pulmonary Hypertension Newborn

Page 12: Respiratory distress syndrome

Apnea of Prematurity• the cessation of pulmonary airflow for

specific time interval, usually longer than10-20s

• central apnea complete cessation air flow and respiratory effort with no chest movement

• obstructive apnoa no airflow but chest movement presents

• Common in premature infants, because they usually responds paradoxically to hypoxia by developing apnea rather than increasing in respiration as do mature infants

Page 13: Respiratory distress syndrome

Pulmonary Air Leak• assisted ventilation with high PIP and PEEP can

cause overdistenstion of the alveoli and causing rupture

• should be suspected when child suddenly deteriorated with hypotension, apnea, or bradychardia or when metabolic acidosis persistent

• eg pneumomediastinum, pneumopericardium, interstitial emphysema, pneumothorax, subcutaneous emphysema

• pneumothorax can be diagnosed based on unequal transillumination of the chest

• diagnosis can be made through chest x ray

Page 14: Respiratory distress syndrome
Page 15: Respiratory distress syndrome

Patent Ductus Arteriosus

• in preterm complicated when hypoxemia of RDS, leads to persistent PDA that creates a shunt between pulmonary and systemic circulations.

• left to right shunt (systemic to pulmonary via PDA) lead to heart failure and pulmonary oedema

• clinical features, wide pulse pressure/ bounding pulse, systolic or continous murmur, apnea, hyperactive precordium

• confirm PDA with echo

• treatment, fluid restriction and diuretic administration + indometacin if no improvement after 24-48 hours.

• administered (0.2mg/kg) intravenously every 12 to 24 hours for three doses

Page 16: Respiratory distress syndrome

Intracranial Hemorrhage

• intraventricular hemorrhage is observed in 20% to 40% of premature infants

• higher frequency in infants with RDS who require mechanical ventilation

• cranial ultrasonography is performed in premature neonates less than 32 weeks and 36 weeks or as indicated (suspected seizures)

Page 17: Respiratory distress syndrome

Primary Pulmonary Hypertension of the Newborn

(PPHN)• characterized by severe hypoxemia

without evidence by parenchymal lung or structural heart disease.

• significant right to left shunt through patent foramen ovale, PDA and intrapulmonary channels is another characteristics.

• echo and cardiac catheterisation confirm the diagnosis

Page 18: Respiratory distress syndrome

Infection• complicate the management of

respiratory distress syndrome in various of ways

• including the invasive procedures e.g. venepuncture, catheter or use respiratory equipment

• use of steroids provide access to microorganism as well

• increase incidence of septicaemia secondary to staph epidermis and/or candidal infection

Page 19: Respiratory distress syndrome

Necrotising Enterocolitis

• suspect necrotising enterocolitis if abnormal abdominal finding and during physical examination.

• radiography can be done to confirm the diagnosis

Page 20: Respiratory distress syndrome

Chronic Complication

• Retinopathy of Prematurity

• Bronchopulmonary Dysplasia

• Neurological Impairment

Page 21: Respiratory distress syndrome

Retinopathy of Prematurity• caused by acute and chronic effects of O2

toxicity on the developing blood vessels of the premature infant retina

• cause vasoconstriction -> vaso-obliteration -> neovascularization

• increase risk of ROP if infants have a partial pressure O2 (PaO2) value more than 100mmhg

• to closely monitor and to maintain 50-70mmHg

Page 22: Respiratory distress syndrome

Retinopathy of Prematurity

Page 23: Respiratory distress syndrome

Bronchopulmonary Dysplasia• chronic lung disease define as requirement for oxygen

at corrected gestational age 36 weeks.

• BPD increase as gestational age decrease

• related directly with high volume and/or pressure used for mechanical ventilation or to manage infection, and inflammation

• failure RDS to improve after 2 weeks and the need prolonged mechanical ventilation at CGA 36 weeks are the characteristics of patient of RDS whom BPD develops

• clinical manifestation, O2 dependence,hypercapnia, compensatory metabolic alkalosis, pulmonary hypertension, poor growh and development right sided heart failure.

Page 24: Respiratory distress syndrome

Neurological Impairment

• occurs approximately 10-70% of infants and is related with infant gestational age, the extent and type of intracranial pathology and presence of hypoxia and infections

• Hearing, visual and learning disability needed to be assessed.

Page 25: Respiratory distress syndrome

–Johnny Appleseed

Thank You

Page 26: Respiratory distress syndrome

Reference

• Paediatric Protocol 3rd edition

• Medscape

• Nelson Essentials of Paediatrics 5th edition